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Abstract
Background. Acute myocardial oedema has been documented in experimental
models of ischemia-reperfusion injury or sepsis and is usually investigated by
magnetic resonance imaging. Purpose. We describe a case of acute ventricular
wall thickening documented by echocardiography in a patient developing sepsis
and thrombotic microangiopathy. Case Description. A 40-year-old woman, with
a history of mixed connective tissue disease, was admitted with laryngeal
oedema and fever. She developed Streptococcus pneumoniae septicaemia
and subsequent laboratory abnormalities were consistent with a thrombotic
microangiopathy. Echocardiography revealed an impressive diffuse thickening of
the whole myocardium (interventricular septum 18 mm; posterior wall 16 mm) with
diffuse hypokinesia and markedly reduced left ventricular ejection fraction (31%).
There was also a moderate pericardial effusion. Echocardiography was normal
two months before. The patient died from acute heart failure. Macroscopic and...
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Background. Acute myocardial oedema has been documented in experimental models of ischemia-reperfusion injury or sepsis
and is usually investigated by magnetic resonance imaging. Purpose. We describe a case of acute ventricular wall thickening
documented by echocardiography in a patient developing sepsis and thrombotic microangiopathy. Case Description. A 40-
year-old woman, with a history of mixed connective tissue disease, was admitted with laryngeal oedema and fever. She
developed Streptococcus pneumoniae septicaemia and subsequent laboratory abnormalities were consistent with a thrombotic
microangiopathy. Echocardiography revealed an impressive diffuse thickening of the whole myocardium (interventricular septum
18mm; posterior wall 16mm) with diffuse hypokinesia and markedly reduced left ventricular ejection fraction (31%). There was
also a moderate pericardial effusion. Echocardiography was normal two months before. The patient died from acute heart failure.
Macroscopic and microscopic examination of the heart suggested that the ventricular wall thickening was induced by oedematous
changes, together with an excess of inflammatory cells. Conclusion. Acute ventricular wall thickening that corresponded to
myocardial oedema as a first hypothesis was observed at echocardiography during the course of septicaemia complicated by
thrombotic microangiopathy.
1. Introduction
The rapid development of ventricular thickening at echo-
cardiography is suggestive of interstitial oedema rather
than muscular hypertrophy. Common causes of intersti-
tial oedema are myocarditis and ischemia-reperfusion phe-
nomena. While experimental evidence suggests that septic
cardiomyopathy may also be associated with interstitial
oedematous changes, few data appeared in human cases in
the acute phase of severe sepsis. We discuss the possible
mechanisms of acute ventricular thickening in a complex
case of combined septicaemia, thrombotic microangiopathy
(TMA), and mixed connective tissue disease (MCTD).
2. Case Description
A40-year-old Black African woman presented to the hospital
for rapid onset of facial swelling and dysphagia. Her medical
history included a mild form of MCTD diagnosed in 2006
(Sharp’s syndrome with anti-DNA and anti-RNP antibodies),
three previous episodes of angioneurotic oedema, two recent
episodes of septicaemia (Streptococcus agalactiae and pneu-
moniae), and a tuboovarian abscess treated by laparoscopic
drainage 2 months before.
Her daily treatment included hydroxychloroquine
400mg/d, nebivolol 5mg/d, calcium carbonate 1.25 g/d, and
esomeprazole 20mg/d. On admission, she complained of
facial swelling with laryngeal stridor and fever measured at
39.8∘C. Clinical examination revealed heart rate 119 bpm,
blood pressure 190/90mmHg, respiratory rate 16/min, and
O
2
saturation (pulse oximetry) 94%. Cardiopulmonary aus-
cultation was unremarkable as was abdomen examination.
Laboratory investigations showed C-reactive protein
0.7mg/dL (N < 1.0mg/dL), serum creatinine 0.56mg/dL,
sodium 138mmol/L, potassium 3.05mmol/L, lactate dehy-
drogenase (LDH) 296 IU/L (N < 248 IU/L), hemoglobin
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10.5 g/dL, white blood cell count 6740/𝜇L, and platelet
count 158 000/𝜇L. Urinalysis failed to reveal leukocyturia
or bacteriuria, and chest X-ray examination was normal.
She was immediately administered 1 g methylprednisolone
intravenously (i.v.) and 1 g tranexamic acid i.v., together
with aerosol therapy, but her clinical condition rapidly
deteriorated with a worsening of laryngeal stridor. She
became hypoxemic and finally required orotracheal intu-
bation and mechanical ventilation. Antimicrobial therapy
with ceftazidime was initiated after taking blood cultures.
Endoscopic laryngoscopy ruled out epiglottitis. At contrast-
enhanced abdominal computed tomography (CT), there
was no recurrence of tuboovarian abscess or other obvious
sources of infection. Corticosteroids were continued at the
daily dose of 1 g methylprednisolone.
The next days, a marked thrombocytopenia appeared
(platelets 18,000/𝜇L on day 4 and 9,000 on day 5) with signs
of hemolysis (LDH 570 IU/L on day 4, schistocytes 4% on
day 5 and 7% on day 6). Haptoglobin was <10mg/dL (N
30–200mg/dL) on day 5. A thrombotic microangiopathy
(TMA) was suspected. Anti-heparin/platelet factor 4
antibodies were undetectable. Admission blood cultures
grew for Streptococcus pneumoniae and ceftazidime was
replaced by ceftriaxone. Plasma exchange was considered. To
evaluate filling pressures, a transthoracic echocardiography
was performed on day 6. Surprisingly, it revealed an
impressive diffuse thickening of the whole myocardium
(interventricular septum 18mm; posterior wall 16mm) with
diffuse hypokinesia and markedly reduced left ventricular
ejection fraction (31%) (Figure 1). Left ventricle end-
diastolic and end-systolic diameters were 41mm and
36mm, respectively. A moderate pericardial effusion (9mm)
was also observed without hemodynamic changes. There
was no increase in cardiac biomarkers. Importantly, an
echocardiography had been performed 2 months before and
was unremarkable. At this time, cardiac output still seemed
satisfactory with normal diuresis, normal lactate level, and
no need for inotropic or vasopressor support. Several hours
later, she suddenly presented electromechanical dissociation
with cardiac arrest before initiation of plasma exchange.
Cardiopulmonary resuscitation was immediately initiated
and pericardial puncture was performed in the same time but
removed less than 10mL serohemorrhagic fluid. Spontaneous
circulation could not be restored and the patient was declared
dead. An autopsy was performed. No source of infection was
found. A small pericardial effusion was confirmed (210mL
of serohemorrhagic fluid). Macroscopic examination of
the heart revealed diffuse thickening of the myocardium.
Ultrastructural examination confirmed oedematous thick-
ening of the myocardium with an excess of inflammatory
cells (mononuclear and polymorphonuclear cells) and small
hemorrhagic spots (Figure 2). No vascular thrombus or
myocardial infarction was observed. No amyloid substance
deposit was shown with red Congo staining. Examination of
the pericardium revealed slight infiltration by lymphoid cells
(Figure 3). Protease ADAMTS13 activity was determined
postmortem and was undetectable in the blood sample
drawn before cardiac arrest (N > 40). No inhibitor of the
protease ADAMTS13 was detected suggesting that the deficit
was hereditary. Common viral causes of myocarditis were
excluded by extensive laboratory investigations.
3. Discussion
We report a fatal case of ventricular wall thickening caused
by myocardial oedema in the course of an episode of TMA
possibly induced by a Streptococcus pneumoniae septicaemia
in a patient with a MCTD.
Myocardial oedema (MO) has been widely observed
by magnetic resonance imaging (MRI) in various car-
diac conditions involving ischemia-reperfusion phenomena
like myocardial infarction, Takotsubo syndrome, cardiopul-
monary bypass, heart transplantation, or resuscitation [1]. It
correlates on pathological examination with cardiomyocytes
swelling and interstitial oedema. Mechanisms involved are
increased vascular permeability induced by inflammatory
mediators (VGEF, MMP, and thrombin) causing endothelial
contraction, osmotic modification in the ischemic region,
and Na+ overload of the myocytes and platelet activation.
MO has also been described in several conditions other
than ischemia-reperfusion.These include increased afterload
and inflammation associated with sepsis, viral myocarditis,
or autoimmune diseases. Pathological heart examination
of patients dying from septic shock frequently may reveal
mononuclear infiltrates and interstitial oedema but the speci-
ficity of these observations is probably very low [2]. In
the early phase of sepsis, MO has been poorly described
and only in animal models where it has been shown to
precede cardiac dysfunction [3, 4]. Moreover, in this setting,
involved mechanisms seem to be different as it incriminates
interendothelial cell junction damages [5].
MO is best detected byMRI, but this examination cannot
be safely performed in critically ill patients and is usually
replaced by bedside echocardiography. The most common
echocardiographic features are however not specific for
MO. Experience is mostly available from acute myocarditis,
where an acute change in ventricular wall thickness is
reflecting oedema formation and cell infiltration [6]. Some
authors have indeed reported that echocardiographic
tissue characterization of the myocardium using ultrasonic
backscatter could be helpful to investigate changes in
myocardial density and elasticity that could occur in
myocarditis [7, 8]. These data are unfortunately not available
in our patient. However, we believe that the acute onset
of left ventricular hypertrophy at echocardiography was a
valuable sign suggestive ofMO.This finding can be compared
to acute left ventricular hypertrophy due to massive MO
that has been described in animal models within the first
minutes of reperfusion after 90min occlusion of a major
epicardial vessel [9]. A similar echocardiographic feature
due to acute myocardial oedema formation has also been
reported following the autonomic storm of brain death [10].
In our patient,MOmay have been induced by several fac-
tors including connective tissue disease and sepsis. Whether
TMA played a role in the observed cardiac involvement
remains questionable. Both Streptococcus pneumoniae septi-
caemia and MCTD have been associated with TMA [11, 12].
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Figure 1: Telediastolic parasternal long (panel (a)) and short (panel (b)) axis view showing normal thickness of the myocardium 2 months
before admission. Panels (c) and (d) show telediastolic parasternal long and short axis view, respectively, of the same patient, 6 days after
admission. Impressive diffuse myocardium thickening is observed.
Figure 2: Ultrastructural examination of the myocardium showing
diffuse interstitial oedema with mononuclear cells inflammatory
infiltration.
Several cardiac events associated with thrombotic microan-
giopathy have already been observed in rare case reports or
cohort studies [13].These includemyocardial infarction, con-
gestive heart failure, and arrhythmias. Reduced left ventricu-
lar function, wall motion abnormalities, pericardial effusion,
Figure 3: Ultrastructural examination of the pericardium showing
rare hemorrhagic spots with a slight infiltration of inflammatory
cells.
and tamponade are echocardiographic findings occasionally
described. Autopsies with ultrastructural examination of
the heart reported presence of thrombi in arterioles and
capillaries,myocardial hemorrhage,myocardial infarction, or
endocarditis [13]. Surprisingly, we observed in our patient
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an impressive myocardial thickening with decreased left
ventricular ejection fraction that correlated with ultrastruc-
tural examination showing an oedematous infiltration of the
myocardium. No histologic sign was found that suggested
a cardiac involvement caused by TMA. The infiltration of
inflammatory cellswith presence of pericardial effusion could
also correspond to a certain degree of myocarditis that
may have progressed despite prolonged administration of
corticosteroids. The true prevalence of cardiac involvement
in MCTD is not precisely known, as most patients remain
poorly symptomatic [14]. Pericardial effusion is the most
frequent echocardiographic sign, but myocardial thickening
is not mentioned in the patients who developed biopsy-
proven acute fulminant myocarditis [14, 15].
4. Limitations
Several other points remain unclear. First, while this episode
of TMA seemed to be related to infection and/or to MCTD,
the origin of Streptococcus pneumoniae septicaemia was
not found, even at autopsy. Second, the sudden onset of
electromechanical dissociation without any previous sign of
low cardiac output was surprising, even if nonischemic acute
heart failure has been exceptionally reported in TMApatients
[16]. This seemed to be induced by the rapid worsening of
cardiac oedema, rather than by the pericardial effusion that
remained limited. Third, as plasma exchange could not be
initiated before the patient’s deterioration, it is not known
whether it could have improved the outcome.
5. Conclusions
We report the case of a young woman who developed
fatal acute cardiac oedema in the course of an episode of
TMA after a Streptococcus pneumoniae septicaemia.Whether
this cardiac involvement was directly associated with sepsis,
TMA, or a certain degree of myocarditis is unclear. Clinicians
should recognize this pattern mimicking hypertrophic car-
diomyopathy as a probable marker of poor prognosis in case
of sepsis or TMA.
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